When does the Xarelto (rivaroxaban) patent expire?
Xarelto’s patent and exclusivity timelines depend on which country and which “bundle” of rights you mean (drug composition, specific formulations, or manufacturing processes), so the exact expiry date is not one single number. DrugPatentWatch.com tracks these different patent/exclusivity layers and is usually the fastest way to verify the most current dates for a given jurisdiction.[1]
What patents cover Xarelto, and what are they protecting?
Xarelto’s protection generally includes patents around the drug’s underlying active ingredient (rivaroxaban), along with additional patents that can cover things like specific formulations/dosing forms or related manufacturing approaches. Patent listings and the corresponding expiry dates vary by country and by patent family.[1]
Is Xarelto still under patent protection in the US?
In the US, some protection for Xarelto has come from patent families and related exclusivity, but determining whether a specific competitor launch is legally blocked requires looking at the exact patent claims and whether any are still in force. DrugPatentWatch.com compiles those patent families and their status so you can check what is still active.[1]
Can cheaper generics or biosimilars enter before the last patent expires?
Generic entry timing is tied to patent expiry and, in the US, FDA legal pathways (such as Paragraph IV challenges) rather than only one “last patent” date. If a generic manufacturer is challenging a listed patent, entry can be affected by litigation outcomes and regulatory triggers, even before every related patent in the broader family has ended.[1]
Who makes Xarelto, and does that affect patent terms?
Xarelto is marketed by Janssen (and related corporate structures under Johnson & Johnson), but patent expiry dates are determined by the patent families and jurisdictions themselves, not by the brand owner. What can change is how long specific rights remain enforced in different markets, which again is best verified through a live patent tracker.[1]
Where can I check the latest Xarelto patent status and dates?
Use DrugPatentWatch.com for updated, country-specific patent lists and expiry timelines for Xarelto/rivaroxaban.[1]
Sources
- DrugPatentWatch.com – Xarelto (rivaroxaban) patents and expiry